<SEC-DOCUMENT>0001607062-15-000232-index.html : 20150602 <SEC-HEADER>0001607062-15-000232.hdr.sgml : 20150602 <ACCEPTANCE-DATETIME>20150602160239 ACCESSION NUMBER: 0001607062-15-000232 CONFORMED SUBMISSION TYPE: PRE 14A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150602 FILED AS OF DATE: 20150602 DATE AS OF CHANGE: 20150602 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: PRE 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 15906889 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 </SEC-HEADER> <DOCUMENT> <TYPE>PRE 14A <SEQUENCE>1 <FILENAME>gnbt60215sch14a.htm <DESCRIPTION>SCHEDULE 14A <TEXT> Document 1 - file: gnbt60215sch14a.htm
</DOCUMENT> </SEC-DOCUMENT>